Therapeutic windows and opportunity cost cast upon prostate cancer's fatal shore

Ann Oncol. 2013 Jul;24(7):1717-1720. doi: 10.1093/annonc/mdt234.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Androstenes
  • Androstenols / therapeutic use*
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Benzamides
  • Bone Neoplasms / drug therapy*
  • Docetaxel
  • Humans
  • Male
  • Nitriles
  • Phenylthiohydantoin / analogs & derivatives*
  • Phenylthiohydantoin / pharmacology
  • Prostatic Neoplasms / drug therapy*
  • Taxoids / pharmacology*

Substances

  • Androstenes
  • Androstenols
  • Antineoplastic Agents
  • Benzamides
  • Nitriles
  • Taxoids
  • Docetaxel
  • Phenylthiohydantoin
  • enzalutamide
  • abiraterone